Health plans should operationalize guidance through formulary design, prior authorization, and step therapy aligned to risk-benefit principles, rather than erecting access barriers to opioids. Dosage ...
Scope expansion in 2022 moved beyond chronic noncancer pain to all outpatient adults with pain, with broadened guidance on dosing, duration, tapering, discontinuation, and follow-up. State and system ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results